Astrazeneca Plc (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,797,000 | 6,916,000 | 7,841,000 | 5,840,000 | 4,871,000 |
| Marketable Securities | 149,000 | 188,000 | 191,000 | 238,000 | 341,000 |
| Receivables | 13,547,000 | 12,622,000 | 12,225,000 | 13,552,000 | 11,997,000 |
| Inventories | 5,662,000 | 5,667,000 | 5,337,000 | 5,424,000 | 5,292,000 |
| TOTAL | $24,155,000 | $25,393,000 | $25,594,000 | $25,054,000 | $22,501,000 |
| Non-Current Assets | |||||
| PPE Net | 10,135,000 | 9,630,000 | 9,411,000 | 9,402,000 | 8,723,000 |
| Investments And Advances | 2,464,000 | 2,088,000 | 1,908,000 | 1,905,000 | 1,441,000 |
| Intangibles | 60,533,000 | 60,486,000 | 58,812,000 | 58,137,000 | 57,626,000 |
| Other Non-Current Assets | 7,635,000 | 6,743,000 | 6,568,000 | 6,621,000 | 5,795,000 |
| TOTAL | $80,767,000 | $78,947,000 | $76,699,000 | $76,065,000 | $73,585,000 |
| Total Assets | $104,922,000 | $104,340,000 | $102,293,000 | $101,119,000 | $96,086,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,253,000 | 5,067,000 | 6,050,000 | 5,129,000 | 5,372,000 |
| Accounts payable and accrued liabilities | 21,684,000 | 20,463,000 | 19,699,000 | 22,374,000 | 20,542,000 |
| Other current liabilities | 1,204,000 | 1,219,000 | 1,240,000 | 1,184,000 | 1,276,000 |
| TOTAL | $25,926,000 | $28,566,000 | $28,901,000 | $30,542,000 | $28,588,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 28,887,000 | 27,225,000 | 27,259,000 | 22,365,000 | 22,225,000 |
| Other Non-Current Liabilities | 5,732,000 | 5,617,000 | 6,011,000 | 6,202,000 | 5,296,000 |
| TOTAL | $38,191,000 | $36,176,000 | $35,891,000 | $31,411,000 | $30,277,000 |
| Total Liabilities | $64,117,000 | $64,742,000 | $64,792,000 | $61,953,000 | $58,865,000 |
| Shareholders' Equity | |||||
| Common Shares | 388,000 | 388,000 | 388,000 | 388,000 | 387,000 |
| Retained earnings | 3,138,000 | 1,847,000 | -212,000 | 1,502,000 | -434,000 |
| Other shareholders' equity | 2,076,000 | 2,164,000 | 2,131,000 | 2,088,000 | 2,102,000 |
| TOTAL | $40,805,000 | $39,598,000 | $37,501,000 | $39,166,000 | $37,221,000 |
| Total Liabilities And Equity | $104,922,000 | $104,340,000 | $102,293,000 | $101,119,000 | $96,086,000 |